Molecular features and clinical implications of the heterogeneity in Chinese patients with HER2-low breast cancer

The molecular heterogeneity and distinct features of HER2-low breast cancers, particularly in the Chinese population, are not well understood, limiting its precise management in the era of antibody‒drug conjugates. To address this issue, we established a cohort of 434 Chinese patients with HER2-low...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Lei-Jie, Ma, Ding, Xu, Yu-Zheng, Li, Ming, Li, Yu-Wei, Xiao, Yi, Jin, Xi, Wu, Song-Yang, Zhao, Ya-Xin, Wang, Han, Yang, Wen-Tao, Jiang, Yi-Zhou, Shao, Zhi-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444861/
https://www.ncbi.nlm.nih.gov/pubmed/37607916
http://dx.doi.org/10.1038/s41467-023-40715-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444861/
https://www.ncbi.nlm.nih.gov/pubmed/37607916
http://dx.doi.org/10.1038/s41467-023-40715-x

Ejemplares similares